SynopsisThe global R-141B market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for R-141B is estimated to increase from $ million in 2023 to r.....
SynopsisThe global R-142B market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for R-142B is estimated to increase from $ million in 2023 to r.....
SynopsisOfloxacin is in a class of medications called quinolone antibiotics. It works by killing bacterial cells that cause infection. The global Ofloxacin Eye Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnes.....
SynopsisNaphazoline is a medicine used as a decongestant. It is a sympathomimetic agent with marked alpha adrenergic activity. It is a vasoconstrictor with a rapid action in reducing swelling when applied to mucous membrane. It acts on alpha-receptors in the arteriole.....
SynopsisThe global Anti-inflammatory Antibiotics EyeDrops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Anti-inflammatory Antibioti.....
SynopsisThe global Antiviral Agents EyeDrops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, grow.....
SynopsisCorticosteroid eye drops are used to treat severe, long-term eye allergy symptoms. Prescription steroid eye drops include loteprednol (Alrex, Lotemax). The global Corticosteroid Eyedrops market was valued at US$ million in 2023 and is anticipated to reac.....
SynopsisThe global Anti Glaucoma Eyedrops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing.....
SynopsisThe global Mydriatic Eyedrops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at .....
SynopsisThe global Eyedrops for Cataract market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing .....
